Related Experiment Video
Updated: Jul 14, 2026
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Vagus nerve stimulation for medically refractory epilepsy: a long-term follow-up study
J J Ardesch1, H P J Buschman, L J J C Wagener-Schimmel
1Medisch Spectrum Twente, Enschede, Neurology, Haaksbergerstraat 55, 7513 ER Enschede, The Netherlands. j.ardesch@ziekenhuis-mst.nl
Seizure
|June 5, 2007
Summary
Vagus nerve stimulation (VNS) effectively reduces seizures in patients with drug-resistant epilepsy over several years. Efficacy extends beyond seizure reduction, with improvements in quality of life observed.
Area of Science:
- Neurology
- Epilepsy Research
- Neurosurgery
Background:
- Pharmacoresistant epilepsy poses significant challenges to patient quality of life.
- Vagus nerve stimulation (VNS) is a therapeutic option for epilepsy refractory to medication.
- Long-term VNS outcomes in pharmacoresistant epilepsy require further investigation.
Purpose of the Study:
- To evaluate the long-term efficacy and outcomes of vagus nerve stimulation (VNS) in patients with pharmacoresistant epilepsy.
- To assess seizure frequency reduction and other efficacy measures over an extended follow-up period.
- To determine if VNS efficacy persists and identify factors beyond seizure reduction that indicate successful treatment.
Main Methods:
- A prospective, long-term descriptive study involving 19 patients with pharmacoresistant epilepsy.
- Patients received vagus nerve stimulator (VNS) implantation between April 1999 and October 2001.
- Efficacy was measured by seizure rate changes compared to a 5-month baseline, with follow-up ranging from 2 to 6 years.
Main Results:
- Progressive seizure reduction was observed, reaching 50% by year 6 in a subset of patients.
- Two patients achieved independent living due to VNS efficacy.
- Adverse effects included hoarseness and coughing; one patient experienced temporary vocal cord paralysis.
Conclusions:
- Vagus nerve stimulation (VNS) demonstrates sustained effectiveness in treating pharmacoresistant epilepsy over multiple years.
- Seizure reduction alone may not fully capture the benefits of VNS; other outcome measures are crucial.
- VNS is a valuable long-term treatment option for epilepsy that is resistant to conventional therapies.
